Legal & General Group Plc - TALIS BIOMEDICAL CORP ownership

Back to all holdings Add to watchlist

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 42 filers reported holding TALIS BIOMEDICAL CORP in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

Legal & General Group Plc ownership history of TALIS BIOMEDICAL CORP
	Value		Shares		Weighting
Q1 2022	$2,000	-50.0%	1,074	0.0%	0.00%	–
Q4 2021	$4,000	-42.9%	1,074	0.0%	0.00%	–
Q3 2021	$7,000	-41.7%	1,074	0.0%	0.00%	–
Q2 2021	$12,000	-29.4%	1,074	-19.2%	0.00%	–
Q1 2021	$17,000	–	1,330	–	0.00%	–
Download

Other shareholders

TALIS BIOMEDICAL CORP shareholders Q3 2021
Name	Shares	Value	Weighting ↓
Greenlight Capital	2,235,783	$1,073,176	0.05%
WELLS FARGO & COMPANY/MN	174	$84	0.00%
NORTHERN TRUST CORP	27,860	$13,373	0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0	$0	0.00%
GEODE CAPITAL MANAGEMENT, LLC	140,530	$67,454	0.00%
STATE STREET CORP	47,436	$22,769	0.00%
MILLENNIUM MANAGEMENT LLC	91,463	$43,902	0.00%
DEUTSCHE BANK AG\	45,294	$21,741	0.00%
MORGAN STANLEY	61,857	$29,691	0.00%
BlackRock Inc.	76,307	$36,628	0.00%

View complete list of TALIS BIOMEDICAL CORP shareholders